MiNK Therapeutics to Participate in 4th Annual Evercore ISI HealthCONx Conference

Rhea-AI Summary

MiNK Therapeutics announced that Dr. Jennifer Buell, President and CEO, will participate in a fireside chat hosted by Evercore on December 1, 2021, at 8:25 AM ET. This event will focus on the company's innovative allogeneic invariant natural killer T (iNKT) cell therapies aimed at treating cancer and immune-mediated diseases. Interested parties can register for the event online, and a replay will be available afterward on the MiNK website.

For further details about MiNK Therapeutics and its clinical-stage developments, visit their official website.

NEW YORK, Nov. 17, 2021 (GLOBE NEWSWIRE) -- MiNK Therapeutics, a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases today announced that Dr. Jennifer Buell, President and CEO of MiNK, will participate in a fireside chat hosted by Evercore on December 1^st, 2021, at 8:25 AM ET.

Registration can be completed in advance at https://wsw.com/webcast/evercore21/register.aspx?conf=evercore21&page=inkt&url=https://wsw.com/webcast/evercore21/inkt/2372244

A replay will be available after the call on the Events and Presentations page of the MiNK website at https://investor.minktherapeutics.com/events-and-presentations

About MiNK Therapeutics
MiNK Therapeutics is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. MiNK is advancing a pipeline of both native and next-generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery. The company is headquartered in New York, NY. For more information, please visit https://minktherapeutics.com/.

Contact
MiNK Therapeutics 
Kimberly Ha
KKH Advisors
917-291-5744
kimberly.ha@kkhadvisors.com

FAQ

What is the date and time of the MiNK Therapeutics fireside chat?

The MiNK Therapeutics fireside chat is scheduled for December 1, 2021, at 8:25 AM ET.

Who is hosting the fireside chat for MiNK Therapeutics?

The fireside chat for MiNK Therapeutics is hosted by Evercore.

Where can I register for the MiNK Therapeutics fireside chat?

You can register for the MiNK Therapeutics fireside chat online via the Evercore website.

Will there be a replay of the MiNK Therapeutics fireside chat?

Yes, a replay of the MiNK Therapeutics fireside chat will be available on their Events and Presentations page.

What type of therapies does MiNK Therapeutics develop?

MiNK Therapeutics develops allogeneic invariant natural killer T (iNKT) cell therapies for cancer and immune-mediated diseases.